Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455859-09-000003
Filing Date
2009-08-31
Accepted
2009-08-31 18:15:18
Documents
1
Period of Report
2009-08-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3764
  Complete submission text file 0001455859-09-000003.txt   5762
Mailing Address 2200 WILSON BLVD. SUITE 102-316 ARLINGTON VA 22201
Business Address 2200 WILSON BLVD SUITE 102-316 ARLINGTON VA 22201 703-526-0400
CHAMPIONS BIOTECHNOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 233 EAST REDWOOD ST BALTIMORE MD 21202
Business Address
Poliakoff Abba David (Reporting) CIK: 0001423066 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 091047085